Assisted Reproduction Unit, 3rd Department of Obstetrics and Gynecology, University of Athens, Attikon Hospital, Chaidari, Greece.
Hum Reprod Update. 2013 Mar-Apr;19(2):105-23. doi: 10.1093/humupd/dms051. Epub 2012 Dec 18.
In response to the ongoing debate on the long-term effects of assisted reproduction technologies, such as IVF, we systematically reviewed and meta-analyzed available evidence on the association between controlled ovarian hyperstimulation for IVF and risk of ovarian, endometrial and cervical cancer.
Eligible studies were identified and pooled effect estimates for relative risk (RR) were calculated by cancer type among two reference groups (general population or infertile women), through fixed- or random-effects models as appropriate.
Nine cohort studies were synthesized, corresponding to a total size of 109 969 women exposed to IVF, among whom 76 incident cases of ovarian, 18 of endometrial and 207 cases of cervical cancer were studied. The synthesis of studies with general population as the reference group pointed to a statistically significant positive association between IVF and increased risk for ovarian (RR = 1.50, 95% confidence interval (CI): 1.17-1.92) and endometrial (RR = 2.04, 95% CI: 1.22-3.43), but not cervical (RR = 0.86, 95% CI: 0.49-1.49) cancers. On the contrary, when infertile women were used as the reference group, no significant associations with ovarian, endometrial or cervical cancer types were noted (RR = 1.26, 95% CI: 0.62-2.55 RR = 0.45, 95% CI: 0.18-1.14 and RR = 5.70, 95% CI: 0.28-117.20, respectively).
IVF does not seem to be associated with elevated cervical cancer risk, nor with ovarian or endometrial cancer when the confounding effect of infertility was neutralized in studies allowing such comparisons. Of note, only one study provided follow-up longer than 10 years for the group exposed to IVF. Future cohort studies should preferably use infertile women as the reference group, rely on IVF-registered valid exposure data, adjust for a variety of meaningful confounders and adopt relatively longer follow-up periods before sound conclusions are drawn.
针对辅助生殖技术(如 IVF)的长期影响这一持续存在的争议,我们系统地回顾和荟萃分析了现有关于 IVF 控制性卵巢刺激与卵巢癌、子宫内膜癌和宫颈癌风险之间关联的证据。
确定符合条件的研究,并通过固定或随机效应模型(视情况而定),按癌症类型计算两个参考组(一般人群或不孕妇女)之间相对风险(RR)的合并效应估计值。
综合了 9 项队列研究,共纳入了 109969 名接受 IVF 治疗的女性,其中 76 例卵巢癌、18 例子宫内膜癌和 207 例宫颈癌病例。以一般人群为参考组的研究综合结果表明,IVF 与卵巢癌(RR = 1.50,95%置信区间(CI):1.17-1.92)和子宫内膜癌(RR = 2.04,95%CI:1.22-3.43)风险增加呈统计学显著正相关,但与宫颈癌(RR = 0.86,95%CI:0.49-1.49)无关。相反,当以不孕妇女为参考组时,未发现与卵巢癌、子宫内膜癌或宫颈癌类型有关联(RR = 1.26,95%CI:0.62-2.55;RR = 0.45,95%CI:0.18-1.14;RR = 5.70,95%CI:0.28-117.20)。
在研究中消除了不孕的混杂影响后,IVF 似乎与宫颈癌风险升高无关,也与卵巢癌或子宫内膜癌无关。值得注意的是,只有一项研究对接受 IVF 治疗的组提供了超过 10 年的随访。未来的队列研究最好使用不孕妇女作为参考组,依赖于 IVF 登记的有效暴露数据,调整各种有意义的混杂因素,并在得出可靠结论之前采用相对较长的随访期。